AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 41 min read$OSCR

Baltrus Victoria sold $33K of OSCR

Baltrus Victoria (Chief Accounting Officer) sold 1,523 shares of Oscar Health, Inc. (OSCR) at an average of $21.94 ($21.74–$22.45) across 2 trades on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Baltrus Victoria
Published Jun 4, 2026, 8:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 4:02 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$OSCR
Neutral
high confidence
Mentioned
$OSCR
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OSCRNeutralLow
01

Why it matters

The disclosed sale is modest and unlikely to move the stock significantly.

02

Market read

Routine insider sell with limited market impact.

03

What to watch

The officer retains a large stake (214,589 shares) indicating continued confidence.

Relevance 2/10Novelty 2/10Timing: post‑market filing on 2026‑06‑04

Background

Form 4 filings disclose insider transactions; a 10b5-1 plan allows pre‑scheduled sales.

Company-level read

Ticker impact

$OSCRNeutralHigh confidence
Context

Chief Accounting Officer Baltrus Victoria sold 1,523 shares for $33,416.74 via a 10b5-1 plan.

Expected impact

likely modest pressure as the market prices in the insider sale

Evidence & confidence

The sale is small relative to holdings and typical for a 10b5-1 plan, so impact is limited.

Market effects

Sector

Minimal effect on health‑insurance sector; insider sales are routine.

Regional

No regional impact.

Global

Not globally relevant.

Counterpoint

What could challenge this read

The sale could be a routine liquidity event, not a negative signal.

Key entities

  • Company
    Oscar Health, Inc.

    US‑listed health‑insurance provider (ticker OSCR).

  • Executive
    Baltrus Victoria

    Chief Accounting Officer of Oscar Health.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

OSCR insider trading history →

Related articles

SEP 16
$OSCRHighAI 8/10

OSCR Looks 33.9% Overvalued on GF Value™ as Oscar Health Revises

Oscar Health (OSCR) revised its 2026 forecasts, raising operating earnings outlook by $100M to $600M-$800M and improving medical loss ratio guidance. Revenue guidance remains $18.7B-$19B. GF Value™ indicates OSCR is 33.9% overvalued at $32.44. The company has a strong GF Score™ of 83/100, with high growth and momentum ratings but middling profitability and valuation. Insiders have sold significantly more shares than they've bought.

gurufocus.com2 min
SEP 16
$OSCRHighAI 8/10

Oscar Health boosts 2026 earnings outlook, affirms revenue

Oscar Health (OSCR) updated its 2026 earnings outlook, lowering its Medical Loss Ratio to 81.0%-82.0% and raising earnings from operations to $600M-$800M. The company reaffirmed revenue guidance of $18.7B-$19.0B and maintained SG&A expense ratio targets. The updates will be discussed at its 2026 Investor Day on September 16, 2026.

tipranks.com2 min
SEP 16
$OSCRHighAI 8/10

Oscar Health raises FY26 earnings guidance by $100 million

Oscar Health (OSCR) raised its 2026 earnings guidance by $100 million, citing improved cost controls. The company expects earnings from operations to range from $600 million to $800 million, with a medical loss ratio of 81.0% to 82.0%. Total revenue guidance remains unchanged at $18.7 billion to $19.0 billion. The stock has gained 85.57% over the past year, reaching a 52-week high of $27.59.

scanx.trade2 min